Biogen Inc. (BIIB)
NASDAQ: BIIB
· Real-Time Price · USD
138.66
3.72 (2.76%)
At close: Aug 15, 2025, 3:59 PM
139.60
0.67%
After-hours: Aug 15, 2025, 07:08 PM EDT
Biogen Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 2.76B | 2.6B | 2.38B | 1.7B | 1.91B | 1.07B | 1.05B | 2.29B | 2.62B | 2.9B | 3.42B | 3.68B | 2.65B | 1.75B | 2.26B | 1.54B | 1.74B | 1.22B |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3.46B | 2.14B | 1.47B | 1.24B | 2.15B | 2B | 1.54B | 1.41B | 1.31B | 1.32B |
Long-Term Investments | n/a | 559.1M | 226.7M | 353.4M | 352.3M | 382M | n/a | 100K | 1.98B | 1.87B | 2.23B | 1.83B | 2.6B | 1B | 892M | 968.3M | 915.1M | 821.9M |
Other Long-Term Assets | 637.7M | n/a | 333.8M | 278M | 327.4M | 315.6M | 1.05B | 1.17B | 1.1B | 978.2M | 1.53B | 860.3M | 1.5B | 1B | 1.42B | 968.3M | 915.1M | 821.9M |
Receivables | 2.08B | 2B | 1.87B | 1.99B | 2.08B | 2B | 2.1B | 2.21B | 2.12B | 2.03B | 2.14B | 1.98B | 2B | 2.02B | 1.96B | 2.12B | 2.11B | 2.22B |
Inventory | 2.27B | 2.27B | 2.46B | 2.47B | 2.51B | 2.52B | 2.53B | 2.98B | 1.33B | 1.28B | 1.34B | 1.38B | 1.29B | 1.22B | 1.35B | 1.35B | 1.25B | 1.17B |
Other Current Assets | 850.6M | 757.3M | 752.5M | 674M | 615.3M | 1.17B | 1.18B | 974.1M | 895.9M | 1.41B | 1.42B | 1.5B | 1.65B | 927.4M | 740.8M | 736.3M | 767.9M | 786.1M |
Total Current Assets | 7.97B | 7.63B | 7.46B | 6.83B | 7.11B | 6.76B | 6.86B | 8.45B | 10.43B | 9.76B | 9.79B | 9.77B | 9.74B | 7.92B | 7.86B | 7.16B | 7.18B | 6.72B |
Property-Plant & Equipment | 3.43B | 3.48B | 3.54B | 3.59B | 3.64B | 3.7B | 3.73B | 3.76B | 3.67B | 3.7B | 3.7B | 3.69B | 3.68B | 3.73B | 3.79B | 3.8B | 3.84B | 3.85B |
Goodwill & Intangibles | 15.96B | 16.06B | 16.17B | 16.29B | 14.46B | 14.51B | 14.58B | 14.15B | 7.53B | 7.57B | 7.6B | 7.75B | 7.82B | 7.91B | 7.98B | 8.05B | 8.15B | 8.75B |
Total Long-Term Assets | 20.36B | 20.41B | 20.59B | 21.48B | 19.7B | 19.81B | 19.99B | 19.74B | 14.73B | 14.84B | 14.76B | 15.09B | 15.34B | 15.7B | 16.02B | 16.64B | 17.29B | 17.14B |
Total Assets | 28.33B | 28.03B | 28.05B | 28.31B | 26.8B | 26.57B | 26.84B | 28.19B | 25.16B | 24.6B | 24.55B | 24.85B | 25.08B | 23.61B | 23.88B | 23.81B | 24.47B | 23.85B |
Account Payables | 408.4M | 391.5M | 424.2M | 422.7M | 354.5M | 387M | 403.3M | 440.1M | 445.4M | 491.2M | 491.5M | 383.2M | 434.8M | 398.7M | 589.2M | 427.9M | 375.3M | 430.4M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | 2.04B | 243.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.76B | n/a | n/a |
Short-Term Debt | n/a | 1.75B | 1.75B | 1.75B | n/a | 250M | 150M | 500M | n/a | n/a | n/a | n/a | 999.8M | 999.5M | 999.1M | 998.8M | n/a | n/a |
Other Current Liabilities | 384.6M | 192.3M | 375.8M | 926.1M | 917.8M | 878.9M | 335.1M | 2.66B | 1.32B | 1.25B | 1.19B | 2.17B | 1.34B | 1.29B | 1.24B | 1.26B | 1.45B | 1.32B |
Total Current Liabilities | 3.18B | 5.3B | 5.53B | 5.42B | 3.11B | 3.22B | 3.43B | 5.02B | 3.19B | 3.01B | 3.27B | 3.93B | 5.02B | 3.95B | 4.3B | 4.21B | 3.35B | 3.17B |
Long-Term Debt | 6.28B | 4.55B | 4.55B | 4.55B | 6.29B | 6.29B | 6.79B | 6.79B | 6.28B | 6.28B | 6.28B | 6.28B | 6.28B | 6.28B | 6.27B | 6.27B | 7.27B | 7.27B |
Other Long-Term Liabilities | 799.6M | 751.7M | 732.3M | 744.1M | 556.7M | 777.1M | 781.1M | 747.9M | 776.9M | 935.5M | 944.2M | 1.2B | 1.17B | 1.29B | 1.32B | 1.32B | 1.36B | 1.41B |
Total Long-Term Liabilities | 7.51B | 5.76B | 5.8B | 6.53B | 7.81B | 8.13B | 8.61B | 8.69B | 7.51B | 7.8B | 7.89B | 8.16B | 8.2B | 8.45B | 8.62B | 8.71B | 9.91B | 10.03B |
Total Liabilities | 10.7B | 11.05B | 11.33B | 11.95B | 10.91B | 11.35B | 12.05B | 13.71B | 10.7B | 10.81B | 11.17B | 12.09B | 13.22B | 12.39B | 12.92B | 12.93B | 13.26B | 13.19B |
Total Debt | 6.59B | 6.62B | 6.63B | 6.65B | 6.66B | 6.95B | 7.34B | 7.72B | 6.59B | 6.61B | 6.61B | 6.63B | 7.55B | 7.59B | 7.6B | 7.62B | 7.63B | 7.65B |
Common Stock | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K | 100K |
Retained Earnings | 20.14B | 19.5B | 19.26B | 18.99B | 18.6B | 18.02B | 17.63B | 17.38B | 17.45B | 16.85B | 16.47B | 15.92B | 14.96B | 14.22B | 13.91B | 13.54B | 13.9B | 13.83B |
Comprehensive Income | -238.1M | -174.5M | -136.2M | -145.7M | -146M | -160.5M | -153.7M | -159.3M | -172.8M | -172M | -164.9M | -163.6M | -110.4M | -115.2M | -106.7M | -136.6M | -171.8M | -174.3M |
Shareholders Equity | 17.63B | 16.98B | 16.72B | 16.36B | 15.89B | 15.21B | 14.8B | 14.48B | 14.47B | 13.8B | 13.4B | 12.78B | 11.87B | 11.24B | 10.9B | 10.43B | 10.75B | 10.68B |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | 460.7M | 754.7M | 5.77B | 3.12B | 2.18B | 3.71B | 4.75B | 4.77B | 4.37B | 4.4B | 4.75B | 4.56B |